Torcetrapib

CHF 72.00
In stock
SYN-3011-M0011 mgCHF 72.00
SYN-3011-M0055 mgCHF 120.00
SYN-3011-M01010 mgCHF 198.00
SYN-3011-M05050 mgCHF 682.00
SYN-3011-M100100 mgCHF 1'041.00
 
More Information
Product Details
Synonyms CP-529414
Product Type Chemical
Properties
Formula C26H25F9N2O4
MW 600.5
CAS 262352-17-0
Purity Chemicals ≥95%
Appearance Solid.
Solubility Soluble in DMSO or ethanol.
Declaration Manufactured by SynKinase.
Other Product Data Target: CETP | Kinase Group: Pfizer Licensed | Substrate: N/A

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.
InChi Key CMSGWTNRGKRWGS-NQIIRXRSSA-N
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Torcetrapib (CP-529414) is a CETP inhibitor with an IC(50) of 37nM.
Product References
  1. In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp: F. Marco, et al.; Antimicrob. Agents Chemother. 42, 161 (1998)
  2. Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone: M.J. Forrest, et al. Br. J. Pharmacol. 154, 1465 (2008)
  3. Torcetrapib produces endothelial dysfunction independent of cholesteryl ester transfer protein inhibition: M.A. Connelly, et al.; J. Cardiovasc. Pharmacol. 55, 459 (2010)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.